Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.692,98
0,44%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Adicet Bio Inc (ACET) Adicet Bio Inc (ACET) Notizie

Adicet Bio Inc

ACET
1,73
-0,08 (-4,42%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202422:30BWAdicet Bio Highlights Preclinical Data Supporting IND..
08/4/202413:00BWAdicet Bio to Participate in 2024 Canaccord Genuity Horizons..
28/3/202422:19BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
19/3/202421:10BWAdicet Reports Fourth Quarter and Full Year 2023 Financial..
11/3/202412:00BWAdicet Bio to Participate in a Fireside Chat at the H.C...
01/3/202401:46BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
05/2/202422:01BWAdicet Bio to Participate in a Fireside Chat at the..
02/2/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:39BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
27/1/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:01BWAdicet Bio, Inc. Announces Closing of $98 Million Public..
24/1/202422:34EDGAR2Form 8-K - Current report
24/1/202422:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/1/202405:43BWAdicet Bio, Inc. Announces Pricing of Public Offering
22/1/202422:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/1/202422:28BWAdicet Bio, Inc. Announces Proposed Public Offering
19/1/202422:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/1/202413:01EDGAR2Form 8-K - Current report
04/1/202413:17EDGAR2Form 8-K - Current report
04/1/202413:00BWAdicet Provides Corporate Update and Highlights Strategic..
03/1/202422:01BWAdicet Bio to Host Conference Call to Provide Updates on its..
29/12/202322:50BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
10/12/202318:00BWAdicet Bio Highlights ADI-001 Expansion, Persistence and..
13/11/202322:42EDGAR2Form 8-K - Current report
08/11/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:12EDGAR2Form 8-K - Current report
08/11/202322:10BWAdicet Reports Third Quarter 2023 Financial Results and..
07/11/202313:00BWAdicet Bio to Present at the 2023 Jefferies London..
02/11/202314:00BWAdicet Bio Announces Poster Presentation Highlighting..
31/10/202323:25BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
16/10/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202318:00BWAdicet Bio Announces Poster Presentation at the Upcoming..
03/10/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202323:24BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
27/9/202315:00BWAdicet Bio to Present Three Scientific Posters Highlighting..
31/8/202322:35BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
17/8/202300:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
09/8/202322:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:17EDGAR2Form 8-K - Current report
09/8/202322:15BWAdicet Reports Second Quarter 2023 Financial Results and..
02/8/202322:00BWAdicet Bio to Participate in a Fireside Chat at the..
31/7/202322:50BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
Apertura: 1,81 Min: 1,66 Max: 1,825
Chiusura: 1,81

La tua Cronologia

NASDAQ
ACET
Adicet Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network